Article
HIV-1 diversity, drug-resistant mutations, and viral evolution among high-risk individuals in phase II HIV vaccine trial sites in southern China.
PloS one - 1 Jan 2013
Qi Haiyan, Zhao Ke, Xu Fei, Zhang Xuzhao, Zhang Zhiyong, Yang Li, Li Chunling, Liang Xu, Guo Weigui, Chen Shihai, Liu Zhihao, Zhang Wenyan, Yu Xiao-Fang
Abstract excerpt
HIV-1 prevalence in Guangxi, China, has been growing since 1996, when the first case was reported. Over half of HIV-1 positive patients in Guangxi Province were injecting drug users (IDUs), possibly because of the province's location near drug-trafficking routes. Since a phase II HIV vaccine trial is ongoing there, a current characterization of the subtypes of HIV-1 among IDUs in Guangxi would provide critical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.